Become A Member

  1. Home
  2. 2022 (MAY-JUNE)
  3. AN EXTENSIVE REVIEW OF EXPLORING THE CONCEPT OF 3Rs (RIGHT TIME, RIGHT PATIENT, RIGHT DRUG) IN MANAGEMENT OF COVID-19
Article Image
Pranav C. Patel*1, Shivani J. Gandhi2**Dr. Punit B. Parejiya1

AN EXTENSIVE REVIEW OF EXPLORING THE CONCEPT OF 3Rs (RIGHT TIME, RIGHT PATIENT, RIGHT DRUG) IN MANAGEMENT OF COVID-19

Three devastating pandemics: SARS, Middle East respiratory disease (MERS), and COVID-19 are linked to new coronaviruses that have struck humans in the twenty-first century. All of the viruses that cause acute respiratory tract infections (ARTIs) are extremely infectious and/or have resulted in significant mortality rates. COVID-19 is a highly contagious viral infection caused by a zoonotic new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to the other two coronaviruses such as SARS-CoV-1 and MERS-CoV, SARS-CoV-2 is also likely to have originated from bats, which have long served as reservoirs for deadly coronaviruses. SARS-CoV-2 is thought to have originated as a spill over from an animal coronavirus and then evolved into a human-to-human transmission virus. The virus spreads quickly and evolves in the human population because it is extremely contagious. This review article specifies classification, current statistics, and various treatment approaches. And the ICMR guidelines for mild, moderate, and severe patients for COVID-19. The main pivotal area of my studied methodology is 3R’s so that the right drug is given to the right patient at right time.

 

KEYWORDS: Covid-19, Management, Right Time, Right Patient, Right Drug